Journal ArticleAm J Manag Care · September 1, 2024
OBJECTIVES: The high costs of cancer care can cause significant harm to patients and society. Prostate cancer, the leading nonskin malignancy in men, is responsible for the second-highest out-of-pocket (OOP) payments among all malignancies. Multiple first- ...
Full textLink to itemCite
Journal ArticleJCO Oncol Pract · April 2023
PURPOSE: The implications of high prices for cancer drugs on health care costs and patients' financial burdens are a growing concern. Patients with metastatic castrate-resistant prostate cancer (mCRPC) are often candidates for multiple first-line systemic ...
Full textLink to itemCite
Journal ArticleJCO Oncol Pract · February 2023
PURPOSE: New therapies including oral anticancer agents (OAAs) have improved outcomes for patients with metastatic renal cell carcinoma (mRCC). However, little is known about the quality of end-of-life (EOL) care and systemic therapy use at EOL in patients ...
Full textLink to itemCite
Journal ArticleUrology · October 2022
OBJECTIVE: To examine real-world adherence to oral anticancer agents (OAAs) and its association with outcomes among Medicare beneficiaries with metastatic renal cell carcinoma (mRCC). METHODS: SEER-Medicare retrospective cohort study of patients with metas ...
Full textLink to itemCite
Journal ArticleJ Am Geriatr Soc · August 2022
BACKGROUND: Kidney cancer is the fastest-growing cancer diagnosis in the developed world. About 16% of new cases are stage IV, which has a low five-year survival rate. Many patients with metastatic renal cell carcinoma (mRCC) are older and may have mild co ...
Full textLink to itemCite
Journal ArticleJ Geriatr Oncol · June 2022
BACKGROUND: Dementia and cancer are both more common in adults as they age. As new cancer treatments become more popular, it is important to consider how these treatments might affect older patients. This study evaluates metastatic renal cell carcinoma (mR ...
Full textLink to itemCite
Journal ArticleJCO Oncol Pract · July 2020
PURPOSE: To determine whether the type of delivery system is associated with intensity of care at the end of life for Medicare beneficiaries with cancer. PATIENTS AND METHODS: We used SEER registry data linked with Medicare claims to evaluate intensity of ...
Full textLink to itemCite
Journal ArticleAnn Surg · January 2020
BACKGROUND: Surgical care has been largely untargeted by Medicare payment reforms because episode costs associated with its delivery are not currently well understood. OBJECTIVE: To quantify the costs of inpatient and outpatient surgery in the Medicare pop ...
Full textLink to itemCite
Journal ArticleJ Urol · May 2019
PURPOSE: We investigated how magnetic resonance imaging and post-magnetic resonance imaging biopsy impact decision making in men considering active surveillance. MATERIALS AND METHODS: We reviewed the records of men in the Michigan Urological Surgery Impro ...
Full textLink to itemCite
Journal ArticleBJU Int · May 2019
OBJECTIVE: To examine the association between National Comprehensive Cancer Network (NCCN) risk, number of positive biopsy cores, age, and early confirmatory test results on pathological upgrading at radical prostatectomy (RP), in order to better understan ...
Full textLink to itemCite
Journal ArticleJ Surg Res · April 2019
BACKGROUND: Nearly 1.5 million clinicians in the United States will be affected by Centers for Medicare and Medicaid Services' (CMS) new payment program, the Merit-based Incentive Program (MIPS), where clinicians will be penalized or rewarded based on the ...
Full textLink to itemCite
Journal ArticleUrology · January 2019
OBJECTIVE: To evaluate the stability of physician-specific episode payments for prostatectomy, nephrectomy, and cystectomy in the context of value-based purchasing programs, such as the merit-based incentive payment system. METHODS: We utilized Surveillanc ...
Full textLink to itemCite
Journal ArticleUrology · August 2018
OBJECTIVE: To examine the relationship between the use and results of early confirmatory testing and persistence on active surveillance (AS). METHODS: We identified all men in the Michigan Urological Surgery Improvement Collaborative registry diagnosed wit ...
Full textLink to itemCite
Journal ArticleOncologist · July 2018
PURPOSE: The aim of this study was to estimate Medicare payments for cancer care during the initial, continuing, and end-of-life phases of care for 10 malignancies and to examine variation in expenditures according to patient characteristics and cancer sev ...
Full textLink to itemCite
Journal ArticleAnn Surg Oncol · April 2018
BACKGROUND: Integrated delivery systems (IDSs) are postulated to reduce spending and improve outcomes through successful coordination of care across multiple providers. Nonetheless, the actual impact of IDSs on outcomes for complex multidisciplinary care s ...
Full textLink to itemCite
Journal ArticleJ Oncol Pract · March 2018
PURPOSE: Policy reforms in the Affordable Care Act encourage health care integration to improve quality and lower costs. We examined the association between system-level integration and longitudinal costs of cancer care. METHODS: We used linked SEER-Medica ...
Full textLink to itemCite
Journal ArticleUrology · February 2018
OBJECTIVE: To evaluate the statistical association between routine home health use after prostatectomy, short-term surgical outcomes, and payments. METHODS: We identified all men who underwent a robotic radical prostatectomy from April 1, 2014, to October ...
Full textLink to itemCite
Journal ArticleUrology · January 2018
OBJECTIVE: To investigate payment variation for 3 common urologic cancer surgeries and evaluate the potential for applying bundled payment programs to these procedures. METHODS: Using 2008-2011 Surveillance, Epidemiology, and End Results-Medicare linked da ...
Full textLink to itemCite
Journal ArticleJCO Precision Oncology · January 1, 2018
Purpose Tissue-based gene expression classifiers (GECs) may assist with management decisions in patients with newly diagnosed prostate cancer. We sought to assess the current use of GEC tests and determine how the test results are associated with primary d ...
Full textCite
Journal ArticleAnn Surg Oncol · November 2017
OBJECTIVE: The aim of this study was to investigate whether patient satisfaction, as measured by the Hospital Consumer Assessment of Healthcare Providers and Systems (HCAHPS) survey, is associated with short-term outcomes after major cancer surgery. MATERI ...
Full textLink to itemCite
Journal ArticleCancer · November 1, 2017
BACKGROUND: Both the Centers for Medicare and Medicaid Services' (CMS) Hospital Compare star rating and surgical case volume have been publicized as metrics that can help patients to identify high-quality hospitals for complex care such as cancer surgery. ...
Full textLink to itemCite
Journal ArticleCurr Opin Urol · July 2017
PURPOSE OF REVIEW: The Medicare Access and CHIP Reauthorization Act (MACRA) is a historic bill that was recently passed that establishes how quality measurement and practice patterns will affect physician reimbursement. Alternative payment models (APMs) ar ...
Full textLink to itemCite
Journal ArticleUrol Oncol · June 2016
OBJECTIVE: To investigate the modified frailty index (mFI) as a preoperative predictor of postoperative complications following radical cystectomy (RC) in patients with bladder cancer. MATERIALS AND METHODS: Patients undergoing RC were identified from the ...
Full textLink to itemCite
Journal ArticleBladder Cancer · January 1, 2016
Background: It is estimated that 74,000 men and women in the United States will be diagnosed with bladder cancer and 16,000 will die from the disease in 2015. The incidence of bladder cancer in Caucasian males is double that of African American males, but ...
Full textCite
Journal ArticleNat Rev Urol · January 2015
Surgical robotic use has grown exponentially in spite of limited or uncertain benefits and large costs. In certain situations, adoption of robotic technology provides value to patients and society. In other cases, however, the robot provides little or no i ...
Full textLink to itemCite
Journal ArticleCurr Opin Urol · January 2014
PURPOSE OF REVIEW: To present the recent advances in needle guidance and robotic ultrasound technology which are used for prostate cancer (PCa) diagnosis and management. RECENT FINDINGS: Prostate biopsy technology has remained relatively unchanged. Improve ...
Full textLink to itemCite
Journal ArticleUrology · December 2013
OBJECTIVE: To assess the effect of nerve sparing (NS) quality on self-reported patient urinary outcomes after radical prostatectomy. METHODS: A total of 102 preoperatively potent men underwent laparoscopic or robotic radical prostatectomy; NS was prospecti ...
Full textLink to itemCite
Journal ArticleAdvances in Urology · September 19, 2012
Muscle invasive and recurrent nonmuscle invasive bladder cancers have been traditionally treated with a radical cystectomy and urinary diversion. The urinary diversion is generally accomplished through the creation of an incontinent ileal conduit, continen ...
Full textCite
Journal ArticleJ Urol · July 2010
PURPOSE: Many patients with small adrenal masses undergo total adrenalectomy. We evaluated partial adrenalectomy outcomes by performing a comprehensive literature review. MATERIALS AND METHODS: We performed a PubMed search of the English language literatur ...
Full textLink to itemCite